CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM - ZIOPHARM ONCOLOGY INC ownership

ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 158 filers reported holding ZIOPHARM ONCOLOGY INC in Q2 2016. The put-call ratio across all filers is 0.47 and the average weighting 0.2%.

Quarter-by-quarter ownership
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM ownership history of ZIOPHARM ONCOLOGY INC
ValueSharesWeighting
Q1 2022$177,000
-45.0%
271,056
-8.1%
0.00%
Q4 2021$322,000
-38.7%
294,956
+2.2%
0.00%
-100.0%
Q3 2021$525,000
-31.2%
288,592
-0.1%
0.00%0.0%
Q2 2021$763,000
-34.1%
288,999
-10.1%
0.00%
-50.0%
Q1 2021$1,158,000
+43.0%
321,6070.0%0.00%
+100.0%
Q4 2020$810,0000.0%321,6070.0%0.00%0.0%
Q3 2020$810,000
-23.1%
321,607
+0.1%
0.00%
-50.0%
Q2 2020$1,054,000
+52.8%
321,419
+14.2%
0.00%
+100.0%
Q1 2020$690,000
-40.4%
281,461
+14.8%
0.00%
-50.0%
Q4 2019$1,157,000
+8.0%
245,171
-2.0%
0.00%0.0%
Q3 2019$1,071,000
-25.7%
250,124
+1.2%
0.00%
-33.3%
Q2 2019$1,441,000
+85.7%
247,136
+22.7%
0.00%
+50.0%
Q1 2019$776,000
+100.5%
201,455
-2.8%
0.00%
+100.0%
Q4 2018$387,000
-40.4%
207,167
+2.2%
0.00%0.0%
Q3 2018$649,000
+6.7%
202,693
+0.7%
0.00%0.0%
Q2 2018$608,000
-22.4%
201,362
+0.6%
0.00%
-50.0%
Q1 2018$784,000
-8.5%
200,102
-3.4%
0.00%0.0%
Q4 2017$857,000
-33.3%
207,117
-1.0%
0.00%
-33.3%
Q3 2017$1,284,000
-11.3%
209,152
-10.1%
0.00%0.0%
Q2 2017$1,448,000
-4.5%
232,749
-2.8%
0.00%0.0%
Q1 2017$1,517,000
+13.1%
239,349
-4.5%
0.00%0.0%
Q4 2016$1,341,000
-7.4%
250,649
-2.6%
0.00%0.0%
Q3 2016$1,448,000
+3.5%
257,249
+0.9%
0.00%0.0%
Q2 2016$1,399,000
-22.4%
254,849
+4.9%
0.00%
-25.0%
Q1 2016$1,802,000
+2.0%
242,915
+14.3%
0.00%0.0%
Q4 2015$1,766,000
-6.3%
212,521
+1.6%
0.00%
-20.0%
Q3 2015$1,885,000
-25.0%
209,167
-0.1%
0.01%
-16.7%
Q2 2015$2,514,000
+40.3%
209,467
+25.9%
0.01%
+50.0%
Q1 2015$1,792,000
+136.1%
166,383
+11.1%
0.00%
+100.0%
Q4 2014$759,000
+92.6%
149,783
+0.4%
0.00%
+100.0%
Q3 2014$394,000
-34.0%
149,142
+0.6%
0.00%
-50.0%
Q2 2014$597,000
-10.5%
148,191
+1.8%
0.00%0.0%
Q1 2014$667,000
+5.5%
145,5910.0%0.00%0.0%
Q4 2013$632,000
+32.2%
145,591
+20.4%
0.00%
+100.0%
Q3 2013$478,000
+94.3%
120,891
+3.2%
0.00%0.0%
Q2 2013$246,000
+16.6%
117,171
+1.6%
0.00%0.0%
Q1 2013$211,000115,3790.00%
Other shareholders
ZIOPHARM ONCOLOGY INC shareholders Q2 2016
NameSharesValueWeighting ↓
Belmont Global Advisors, Inc. 2,564,925$11,132,0008.99%
Essex Woodlands Management, Inc. 2,764,908$11,330,0005.70%
Third Security, LLC 17,815,708$77,320,0003.68%
MSD Partners, L.P. 2,750,000$11,935,0000.49%
SFMG, LLC 99,850$433,0000.15%
GM Advisory Group, LLC 12,500$54,0000.06%
Geduld E E 25,000$109,0000.05%
WESTPORT RESOURCES MANAGEMENT INC 30,500$132,0000.04%
Janney Montgomery Scott LLC 335,571$1,456,378,0000.04%
WFG Advisors, LP 48,040$208,0000.03%
View complete list of ZIOPHARM ONCOLOGY INC shareholders